Letters to the EditorInhibitory and bactericidal effect of Artilysin® Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates
Section snippets
Acknowledgments
The mcr-1 colistin-resistant E. coli strain (15-AB00353-0) was kindly provided by the German Bundesinstitut für Risikobewertung (BfR).
Funding: This work was supported by the Research Foundation—Flanders (FWO, Krediet aan navorsers—1.5.171.15N to Y.B., and a SB FWO PhD fellowship—1.S.322.17N to H.G.).
Competing interests: Y.B. acts as a scientific advisor of Lisando GmbH. E.S., M.B. and V.H. are employees of Lisando GmbH.
Ethical approval: Not required.
References (5)
- et al.
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Lancet Infect Dis
(2016) - et al.
China bans colistin as a feed additive for animals
Lancet Infect Dis
(2016)
Cited by (45)
Molecular mechanism of action of imidazolium carbosilane dendrimers on the outer bacterial membrane – From membrane damage to permeability to antimicrobial endolysin
2024, Journal of Colloid and Interface ScienceGram-negative endolysins: overcoming the outer membrane obstacle
2024, Current Opinion in MicrobiologyLysins breaking down the walls of Gram-negative bacteria, no longer a no-go
2021, Current Opinion in BiotechnologyCitation Excerpt :These engineered lysins act rapidly upon contact, are highly bactericidal, are active against persisters, show no cross-resistance with existing resistance mechanisms (including colistin) and do not elicit resistance development upon serial exposure to subinhibitory doses [35,36,37,38]. Such engineered lysins have been reported against the three critical priority pathogens listed by the WHO [1], that is, P. aeruginosa, A. baumannii, and E. coli [35–43] using polycationic [35,40,41], hydrophobic [35,42], amphipathic [35] or antimicrobial peptides [36,43]. Nevertheless, the mere addition of an OMP peptide to the N-terminus or C-terminus of lysin does not automatically result in the best variants and often only moderate activities are observed.
The use of bacteriophages for food safety
2020, Current Opinion in Food ScienceCitation Excerpt :Results demonstrated a 5.5 log CFU reduction, compared to 0.2–0.3 log reduction when either treatment was used individually. The authors concluded that the endolysins substantially increased the anti-bactericidal effect of high pressure, enabling inactivation of bacterial cells at much lower pressure levels [32]. In another combination treatment study, Chang et al. [33] evaluated the synergistic effect of LysSA97 and carvacrol oil for biocontrol of Staphylococcus aureus in foods, including milk and beef and similarly found that when the treatments were used in isolation, an average of 0.8 ± 0.2 and 1.0 ± 0.0 log CFU/mL of S. aureus was observed.
Bacteriophage-derived endolysins to target gram-negative bacteria
2020, International Journal of PharmaceuticsCitation Excerpt :This approach has also been extended to improve the OM permeability and hence lytic activity of lysins against G–ve bacteria (Table 1). Three techniques have been proposed: (1) fusion with membrane-penetrating peptides which have polycationic, hydrophobic or amphipathic properties, termed “Artilysin” (Defraine et al., 2016; Ma et al., 2017; Briers et al., 2014a, 2014b; Schirmeier et al., 2018; Yang et al., 2015); (2) fusion with membrane-translocating domains derived from bacteria (bacteriocins) (Lukacik et al., 2012; Yan et al., 2017; Heselpoth et al., 2019) or a CBD from G + ve lysins (Wang et al., 2017); and (3) truncation of lysins to obtain peptides with bactericidal activity through membrane disruption (Thandar et al., 2016). Gerstmans et al. (Gerstmans et al., 2018) and Ghose et al. (Ghose and Euler, 2020) provided detailed reviews on the engineering approaches used for G–ve lysins.
Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa
2020, Journal of Global Antimicrobial Resistance